Elias Zambidis, M.D., Ph.D.
The Zambidis lab studies the formation of pluripotent stem cells and hematopoietic, endothelial and cardiac differentiation with a focus on the potential therapeutic use of pluripotent stem cell-derived cells. Projects include studying the developmental biology of hematopoiesis as well as improving the differentiation of human embryonic stem cells and human induced pluripotent stem cells to hematopoietic lineages including erythrocytes and lymphocytes; improving the differentiation of human pluripotent stem cells to endothelial cells capable of forming the vasculature system; and improving the differentiation of human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPSC) to the cardiac lineage. The research team also studies the developmental biology of gastrulation and cardiogenesis in model organisms and explores potential applications of pluripotent stem cell-derived cardiac in tissue engineering, regenerative medicine, cardiotoxicity screening and novel drug discovery.
Meet Dr. Zambidis
On using stem cells to study cancer:
View a list of publications on PubMed.